Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Improved CRBN ligands make protein degraders more effective and drug-like.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Certain drugs that block specific enzymes can help treat prostate diseases.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Six existing drugs may help block virus entry in COVID-19.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.